Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Ordinary Shares, par value CHF 0.05 per share
-
Shares outstanding
-
66.4M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
17.7M
-
Shares change
-
+1.14M
-
Total reported value, excl. options
-
$84.1M
-
Value change
-
+$5.49M
-
Number of buys
-
21
-
Number of sells
-
-11
-
Price
-
$4.76
Significant Holders of SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) as of Q3 2025
42 filings reported holding SOPH - SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share as of Q3 2025.
SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.7M shares
of 66.4M outstanding shares and own 26.6% of the company stock.
Largest 10 shareholders include GENERATION INVESTMENT MANAGEMENT LLP (6.79M shares), AKRE CAPITAL MANAGEMENT LLC (3.72M shares), BANQUE PICTET & CIE SA (2.21M shares), Alta Wealth Advisors LLC (1.41M shares), PRINCIPAL FINANCIAL GROUP INC (1.39M shares), Archon Capital Management LLC (427K shares), Bank Pictet & Cie (Europe) AG (255K shares), MILLENNIUM MANAGEMENT LLC (226K shares), FEDERATED HERMES, INC. (210K shares), and EDMOND DE ROTHSCHILD HOLDING S.A. (203K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.